Vancomycin Versus Daptomycin for the Treatment of Methicillin-resistant Staphylococcus Aureus Bacteremia Due to Isolates With High Vancomycin Minimum Inhibitory Concentrations (MICs)
This study has been terminated.
(Low patient enrollment)
Sponsor:
St. John Health System, Michigan
Collaborators:
Henry Ford Health System
Cubist Pharmaceuticals
Information provided by (Responsible Party):
Leonard B. Johnson, St. John Health System, Michigan
ClinicalTrials.gov Identifier:
NCT01287832
First received: January 31, 2011
Last updated: December 14, 2012
Last verified: December 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been terminated. |
|---|---|
| Study Completion Date: | January 2012 |
| Primary Completion Date: | January 2012 (Final data collection date for primary outcome measure) |